Encapsulate Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3.63M

  • Investors
  • 20

Encapsulate General Information

Description

Developer of an automated tumor-on-a-chip technology designed to grow patients' cancer cells outside the body. The company's technology uses cancer cells during initial cancer diagnosis and grows and preserved as microtumors, which are used to evaluate the efficacy of chemotherapeutic or biotherapeutic drugs on an individualized basis, enabling oncologists to understand which treatments are likely to work for a specific patient's tumour.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 400 Farmington Avenue
  • Room 1841
  • Farmington, CT 06032
  • United States
+1 (267)
Primary Industry
Outcome Management (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 400 Farmington Avenue
  • Room 1841
  • Farmington, CT 06032
  • United States
+1 (267)

Encapsulate Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Encapsulate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
16. Grant 08-Jul-2025 $3.63M Completed Clinical Trials - Phase 1
15. Grant 01-Jul-2025 Completed Clinical Trials - Phase 1
14. Accelerator/Incubator 10-Jun-2025 Completed Clinical Trials - Phase 1
13. Accelerator/Incubator 17-Feb-2025 Completed Clinical Trials - Phase 1
12. Later Stage VC 19-Nov-2024 Completed Clinical Trials - Phase 1
11. Accelerator/Incubator 24-May-2023 Completed Clinical Trials - Phase 1
10. Seed Round 01-May-2023 Completed Clinical Trials - Phase 1
9. Accelerator/Incubator 01-Jan-2023 Completed Clinical Trials - Phase 1
8. Grant 01-Jul-2022 $256K $427K Completed Clinical Trials - Phase 1
7. Accelerator/Incubator $427K Completed Pre-Clinical Trials
To view Encapsulate’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Encapsulate Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an automated tumor-on-a-chip technology designed to grow patients' cancer cells outside the body. The compa
Outcome Management (Healthcare)
Farmington, CT
10 As of 2025

Salt Lake City, UT
 

Redwood City, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Encapsulate Competitors (3)

One of Encapsulate’s 3 competitors is Known Medicine, a Formerly VC-backed company based in Salt Lake City, UT.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Known Medicine Formerly VC-backed Salt Lake City, UT
SageMedic Venture Capital-Backed Redwood City, CA
Kiyatec Venture Capital-Backed Greenville, SC
You’re viewing 3 of 3 competitors. Get the full list »

Encapsulate Patents

Encapsulate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260348943-A1 Automated biochips for personalized cancer screening and predictive drug response analysis Pending 02-May-2025
WO-2026231219-A1 Automated biochips for personalized cancer screening and predictive drug response analysis Pending 02-May-2025

Encapsulate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Encapsulate Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioTools Innovator Accelerator/Incubator
MedTech Innovator Accelerator/Incubator
CancerX (USA) Accelerator/Incubator
Ambit Health Ventures Venture Capital Minority
Blackwood Healthcare Breakthroughs Venture Capital Minority
You’re viewing 5 of 20 investors. Get the full list »

Encapsulate FAQs

  • When was Encapsulate founded?

    Encapsulate was founded in 2019.

  • Where is Encapsulate headquartered?

    Encapsulate is headquartered in Farmington, CT.

  • What is the size of Encapsulate?

    Encapsulate has 10 total employees.

  • What industry is Encapsulate in?

    Encapsulate’s primary industry is Outcome Management (Healthcare).

  • Is Encapsulate a private or public company?

    Encapsulate is a Private company.

  • What is Encapsulate’s current revenue?

    The current revenue for Encapsulate is .

  • How much funding has Encapsulate raised over time?

    Encapsulate has raised $2.53M.

  • Who are Encapsulate’s investors?

    BioTools Innovator, MedTech Innovator, CancerX (USA), Ambit Health Ventures, and Blackwood Healthcare Breakthroughs are 5 of 20 investors who have invested in Encapsulate.

  • Who are Encapsulate’s competitors?

    Known Medicine, SageMedic, and Kiyatec are competitors of Encapsulate.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process